Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies

Item request has been placed! ×
Item request cannot be made. ×
  Processing Request
  • Additional Information
    • Publication Information:
      American Society for Clinical Investigation
    • Publication Date:
      2006
    • Subject Terms:
    • Abstract:
      Inhibitory immune response to exogenously infused factor VIII (FVIII) is a major complication in the treatment of hemophilia A. Generation of such inhibitors has the potential to disrupt gene therapy [...]
    • ISSN:
      0021-9738
    • Rights:
      COPYRIGHT 2006 American Society for Clinical Investigation
      Copyright 2006 Gale, Cengage Learning. All rights reserved.
    • Accession Number:
      edsgcl.148673131
  • Citations
    • ABNT:
      SHI, Q. et al. Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies. Journal of Clinical Investigation, [s. l.], n. 7, p. 1974, 2006. Disponível em: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsgsc&AN=edsgcl.148673131&custid=s6224580. Acesso em: 22 jan. 2020.
    • AMA:
      Shi Q, Wilcox DA, Fahs SA, et al. Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies. Journal of Clinical Investigation. 2006;(7):1974. http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsgsc&AN=edsgcl.148673131&custid=s6224580. Accessed January 22, 2020.
    • APA:
      Shi, Q., Wilcox, D. A., Fahs, S. A., Weiler, H., Wells, C. W., Cooley, B. C., … Montgomery, R. R. (2006). Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies. Journal of Clinical Investigation, (7), 1974. Retrieved from http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsgsc&AN=edsgcl.148673131&custid=s6224580
    • Chicago/Turabian: Author-Date:
      Shi, Qizhen, David A. Wilcox, Scot A. Fahs, Hartmut Weiler, Clive W. Wells, Brian C. Cooley, Drashti Desai, Patricia A. Morateck, Jack Gorski, and Robert R. Montgomery. 2006. “Factor VIII Ectopically Targeted to Platelets Is Therapeutic in Hemophilia A with High-Titer Inhibitory Antibodies.” Journal of Clinical Investigation, no. 7: 1974. http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsgsc&AN=edsgcl.148673131&custid=s6224580.
    • Harvard:
      Shi, Q. et al. (2006) ‘Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies’, Journal of Clinical Investigation, (7), p. 1974. Available at: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsgsc&AN=edsgcl.148673131&custid=s6224580 (Accessed: 22 January 2020).
    • Harvard: Australian:
      Shi, Q, Wilcox, DA, Fahs, SA, Weiler, H, Wells, CW, Cooley, BC, Desai, D, Morateck, PA, Gorski, J & Montgomery, RR 2006, ‘Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies’, Journal of Clinical Investigation, no. 7, p. 1974, viewed 22 January 2020, .
    • MLA:
      Shi, Qizhen, et al. “Factor VIII Ectopically Targeted to Platelets Is Therapeutic in Hemophilia A with High-Titer Inhibitory Antibodies.” Journal of Clinical Investigation, no. 7, 2006, p. 1974. EBSCOhost, search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsgsc&AN=edsgcl.148673131&custid=s6224580.
    • Chicago/Turabian: Humanities:
      Shi, Qizhen, David A. Wilcox, Scot A. Fahs, Hartmut Weiler, Clive W. Wells, Brian C. Cooley, Drashti Desai, Patricia A. Morateck, Jack Gorski, and Robert R. Montgomery. “Factor VIII Ectopically Targeted to Platelets Is Therapeutic in Hemophilia A with High-Titer Inhibitory Antibodies.” Journal of Clinical Investigation, no. 7 (2006): 1974. http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsgsc&AN=edsgcl.148673131&custid=s6224580.
    • Vancouver/ICMJE:
      Shi Q, Wilcox DA, Fahs SA, Weiler H, Wells CW, Cooley BC, et al. Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies. Journal of Clinical Investigation [Internet]. 2006 [cited 2020 Jan 22];(7):1974. Available from: http://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edsgsc&AN=edsgcl.148673131&custid=s6224580